December 6, 2022
Via: The Wall Street JournalEmergent BioSolutions Inc., maker of Narcan, a nasal-spray form of naloxone, said Tuesday that the U.S. Food and Drug Administration fast-tracked an application it submitted for an over-the-counter version of its widely used opioid-reversal nasal spray. The company said it […]
November 30, 2023
November 28, 2023
November 21, 2023
November 16, 2023
November 14, 2023
November 7, 2023
December 1, 2023